Cases & Deals

  • Home
  • Practices
  • Pacira BioSciences enters strategic partnership with Molteni Farmaceutici

Share

Pacira BioSciences enters strategic partnership with Molteni Farmaceutici

October 2026

Client(s) Pacira BioSciences, Inc.

Jones Day acted as tax counsel to Pacira BioSciences, Inc. in connection with Pacira’s strategic partnership with Molteni Farmaceutici to expand access to opioid-sparing postsurgical pain management across European markets. Through this partnership, Molteni Farmaceutici will receive exclusive rights to distribute and commercialize EXPAREL® (bupivacaine liposome injectable suspension), Pacira’s long-acting, local analgesic for postsurgical pain management, within the licensed territories.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.